tm logo
ADMINSC
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 01 Jul 2024

Last Applicant/ Owned by

Route 206 & Province Line Road

Princeton

NJ

08543

Serial Number

97690362 filed on 23rd Nov 2022

Registration Number

N/A

Correspondent Address

MARILYN F. KELLY

MARILYN F. KELLY BRISTOL-MYERS SQUIBB COMPANY

TRADEMARK DEPT., MAILSTOP D.4243

PRINCETON, NJ 08648-4000

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ADMINSC

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97690362

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Jul 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
01st Jul 2024ABANDONMENT - NO USE STATEMENT FILED
28th Nov 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03rd Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03rd Oct 2023PUBLISHED FOR OPPOSITION
13th Sep 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28th Aug 2023APPROVED FOR PUB - PRINCIPAL REGISTER
25th Aug 2023TEAS/EMAIL CORRESPONDENCE ENTERED
24th Aug 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
24th Aug 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED